Monday, May 29, 2023
HomeLatest NewsSandoz to exclusively commercialize six products in the US, reinforcing global leadership...

Sandoz to exclusively commercialize six products in the US, reinforcing global leadership position in off-patent medicines

Agreement offers exclusive rights to commercialize six products in key areas of anti-infectives and oncology.Products from Adalvo slated for near- to mid-term launches, with four out of six anticipated to be first-to-marketSandoz continues to expand patient access to much-needed medications,…

Source: www.novartis.comRead more

Must Read

The Top 10 endpoint security challenges and how to overcome them

Join top executives in San Francisco on July 11-12, to hear how leaders are integrating and optimizing AI investments for success. Learn More One of...